ArticleFrontiers in pharmacology2026

Thymidine kinase as a biomarker of chemoresistance in epithelial ovarian cancer using the KELIM model.

David Lukanović et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.